Senator Criticizes FDA for Approach to Oxilofrine in Supplements
Sen. Claire McCaskill (D-Mo.) is taking the FDA to task for its delayed reaction in targeting companies marketing supplements containing oxilofrine, a stimulant banned by the World Anti-Doping Agency for athletes.
Source: Drug Industry Daily